Evidence map›Paper›PMID 38698752›Full record

ArticleCurrent HIV research2024

Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination.

Deniz Borcak, Yusuf Emre Özdemir, Zuhal Yesilbag, Esra Ensaroğlu, Samiha Akkaya, Kadriye Kart Yaşar

Abstract read
PubMed Publisher
In one paragraph

Article in Current HIV research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Deniz BorcakDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0000-0001-7769-4555
Yusuf Emre ÖzdemirDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0000-0002-7428-5091
Zuhal YesilbagDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0000-0002-7210-1084
Esra EnsaroğluDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0009-0000-6014-4258
Samiha AkkayaDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0009-0008-6204-9690
Kadriye Kart YaşarDepartment of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Bakırköy, Istanbul, Turkey.ORCID 0000-0003-2963-4894

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMpox virus is an orthopoxvirus that causes the zoonotic infectious disease known as mpox. The disease can also spread from humans to humans. It can be transmitted through contact with bodily fluids, lesions on the skin, or internal mucosal surfaces.

methodThe number of mpox cases increased during the COVID-19 pandemic. Early diagnosis and prompt management of mpox are critical in people living with HIV (PLHIV). In this study, a cross-sectional survey was conducted among PLHIV followed at the outpatient clinic between 20 April-20 August 2023. A questionnaire was used to assess the knowledge and anxiety levels of patients as well as their opinions about vaccination against mpox. The severity of symptoms in the past two weeks was assessed using the Generalised Anxiety Disorder 7-item scale. A total of 203 PLHIV were interviewed for this survey study.

resultThe mean age was 39.37±11.93. The majority of them were male (86.7%), and 41.4% were men who have sex with men (MSM). Only 21 of the surveyed participants (10.4%) had a "good knowledge" score about mpox. The mean knowledge score on human Mpox was 2.05 (min:0-max:8), and 107 (52.7%) had a score of 0.

conclusionThe future study should focus on continuous education, promoting awareness through programs and establishing measures to successfully overcome identified variables that contribute to mpox pandemic understanding and attitudes. Applying the lessons learned from the COVID-19 pandemic will help the management of mpox virus.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsVaccinationAdultCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedMpox, MonkeypoxSARS-CoV-2Surveys and QuestionnairesYoung AdultCOVID-19human immunodeficiency virusMpoxMpox vaccinePLHIVzoonotic infectious disease.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.